D. Allen Annis, Ph.D.

VP, Biophysical & Analytical Technologies
Aileron Therapeutics
Papers:
Long-acting GHRH Analog ALRN-5281, the First Stapled Peptide Clinical Candidate, Exhibits Robust In Vitro and In Vivo Activation of the Growth Hormone Pathway